Clinical Trial Update: Travacom Post Marketing Surveillance Study [Phase 4]

View source ↗

Summary

A Phase 4 post-marketing surveillance study of Travacom for open-angle glaucoma and ocular hypertension has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• Travacom

Snippet

Sponsor: Alcon Research | Conditions: Open-angle Glaucoma, Ocular Hypertension | Phase 4 | Status: WITHDRAWN